People who experience facial flushing after consuming alcohol may have a heightened risk of developing Alzheimer's disease, according to new research from the University of Florida. The study investigated how acetaldehyde, a toxic compound produced during alcohol metabolism, can affect the brain at a cellular level, particularly in individuals with a specific genetic variation.
Researchers concentrated on the ALDH2 gene, which is responsible for producing an enzyme that converts acetaldehyde into acetate, a less harmful substance that the body can more easily process. However, some individuals carry a variant of this gene, known as ALDH2*2, which impairs the efficient breakdown of acetaldehyde. This inefficiency leads to a buildup of the toxic compound, resulting in symptoms such as facial flushing, nausea, headaches, and rapid heart rate.
The study utilized mice engineered to carry the ALDH2*2 variant to explore the impact of chronic heavy alcohol consumption and acetaldehyde toxicity on brain inflammation, metabolic issues, and tau pathology—a key indicator of Alzheimer's disease. Lead author Nagalakshmi Balasubramanian stated that individuals with this variant struggle to clear acetaldehyde, allowing it to accumulate and promote inflammation and oxidative stress throughout the body, including the brain.
While carrying the ALDH2*2 variant does not guarantee the development of Alzheimer's, Balasubramanian noted that it might contribute to accelerated brain aging and neurodegeneration, especially when combined with chronic heavy alcohol exposure. Heavy drinking, typically defined as more than eight drinks per week for women or 15 for men over extended periods, can leave a lasting negative impact on brain health, the study suggested.
The research, presented at the annual meeting of the Research Society on Alcohol, also explored whether enhancing ALDH2 activity could mitigate alcohol-induced brain damage. The findings indicate that early identification of these genetic variations and molecular warning signs could lead to earlier detection and more targeted therapies before irreversible brain damage occurs.
Balasubramanian added that chronic alcohol use can accelerate biological aging in the brain and exacerbate pathways associated with Alzheimer's. Alcohol can induce inflammation, oxidative stress, and metabolic dysfunction, and may also contribute to depression, anxiety, and social withdrawal, which are often early warning signs of the disease. She emphasized that